Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients

Autor:	Marconi, Giovanni *, De Polo, Stefano, Martinelli, Giovanni, Nanni, Jacopo, Bertamini, Luca, Talami, Annalisa, Olivi, Matteo, Ragaini, Simone, Abbenante, Maria Chiara, Sartor, Chiara, Ottaviani, Emanuela, Bochicchio, Maria Teresa, Parisi, Sarah, Fontana, Maria Chiara, Cristiano, Gianluca, Raffini, Maddalena, Baldazzi, Carmen, Testoni, Nicoletta, Bonifazi, Francesca, Paolini, Stefania, Curti, Antonio, Cavo, Michele, Papayannidis, Cristina *
Zdroj:	In Leukemia Research February 2021 101
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect